Eugenio Uriarte
Eugenio Uriarte
Profesor de Química Medicinal, Universidad de Santiago de Compostela, Universidad Autónoma de Chile
Verified email at
Cited by
Cited by
Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity
F Borges, F Roleira, N Milhazes, L Santana, E Uriarte
Current medicinal chemistry 12 (8), 887-916, 2005
Chromone: a valid scaffold in medicinal chemistry
A Gaspar, MJ Matos, J Garrido, E Uriarte, F Borges
Chemical reviews 114 (9), 4960-4992, 2014
Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices
H Gonzalez-Diaz, S Vilar, L Santana, E Uriarte
Current topics in medicinal chemistry 7 (10), 1015-1029, 2007
Recent advances on the role of topological indices in drug discovery research
E Estrada, E Uriarte
Current Medicinal Chemistry 8 (13), 1573-1588, 2001
Proteomics, networks and connectivity indices
H González‐Díaz, Y González‐Díaz, L Santana, FM Ubeira, E Uriarte
Proteomics 8 (4), 750-778, 2008
Effects of cis‐resveratrol on inflammatory murine macrophages: antioxidant activity and down‐regulation of inflammatory genes
J Leiro, E Alvarez, JA Arranz, R Laguna, E Uriarte, F Orallo
Journal of leukocyte biology 75 (6), 1156-1165, 2004
A novel approach for the virtual screening and rational design of anticancer compounds
E Estrada, E Uriarte, A Montero, M Teijeira, L Santana, E De Clercq
Journal of medicinal chemistry 43 (10), 1975-1985, 2000
Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
EG Yordi, EM Pérez, MJ Matos, EU Villares
Nutrition, well-being and health 2, 23-48, 2012
Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity
L Santana, E Uriarte, F Roleira, N Milhazes, F Borges
Current Medicinal Chemistry 11 (24), 3239-3261, 2004
A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins
L Santana, E Uriarte, H González-Díaz, G Zagotto, R Soto-Otero, ...
Journal of medicinal chemistry 49 (3), 1149-1156, 2006
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin–resveratrol hybrids
S Vilar, E Quezada, L Santana, E Uriarte, M Yánez, N Fraiz, C Alcaide, ...
Bioorganic & Medicinal Chemistry Letters 16 (2), 257-261, 2006
Coumarins—an important class of phytochemicals
MJ Matos, L Santana, E Uriarte, OA Abreu, E Molina, EG Yordi
Phytochemicals-isolation, characterisation and role in human health 25, 533-538, 2015
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure–activity relationships
A Chilin, R Battistutta, A Bortolato, G Cozza, S Zanatta, G Poletto, ...
Journal of medicinal chemistry 51 (4), 752-759, 2008
Drug—drug interaction through molecular structure similarity analysis
S Vilar, R Harpaz, E Uriarte, L Santana, R Rabadan, C Friedman
Journal of the American Medical Informatics Association 19 (6), 1066-1074, 2012
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors
MJ Matos, C Teran, Y Perez-Castillo, E Uriarte, L Santana, D Vina
Journal of medicinal chemistry 54 (20), 7127-7137, 2011
Similarity-based modeling in large-scale prediction of drug-drug interactions
S Vilar, E Uriarte, L Santana, T Lorberbaum, G Hripcsak, C Friedman, ...
Nature protocols 9 (9), 2147-2163, 2014
A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
MJ Matos, D Viña, E Quezada, C Picciau, G Delogu, F Orallo, L Santana, ...
Bioorganic & medicinal chemistry letters 19 (12), 3268-3270, 2009
Quantitative structure− activity relationship and complex network approach to monoamine oxidase A and B inhibitors
L Santana, H Gonzalez-Diaz, E Quezada, E Uriarte, M Yanez, D Vina, ...
Journal of medicinal chemistry 51 (21), 6740-6751, 2008
Hesperidin as a neuroprotective agent: a review of animal and clinical evidence
M Hajialyani, M Hosein Farzaei, J Echeverría, SM Nabavi, E Uriarte, ...
Molecules 24 (3), 648, 2019
Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors
A Gaspar, T Silva, M Yánez, D Vina, F Orallo, F Ortuso, E Uriarte, S Alcaro, ...
Journal of medicinal chemistry 54 (14), 5165-5173, 2011
The system can't perform the operation now. Try again later.
Articles 1–20